Pacer Advisors’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$237K Buy
2,172
+681
+46% +$64.9K ﹤0.01% 1709
2025
Q4
$121K Sell
1,491
-168
-10% -$14.5K ﹤0.01% 2362
2025
Q3
$145K Buy
1,659
+541
+48% +$48.3K ﹤0.01% 2081
2025
Q2
$92.8K Sell
1,118
-1,112
-50% -$92.9K ﹤0.01% 2535
2025
Q1
$187K Sell
2,230
-720
-24% -$67K ﹤0.01% 1783
2024
Q4
$272K Buy
2,950
+228
+8% +$21.9K ﹤0.01% 1802
2024
Q3
$253K Sell
2,722
-11
-0.4% -$953 ﹤0.01% 1805
2024
Q2
$225K Buy
2,733
+1,205
+79% +$88.5K ﹤0.01% 1824
2024
Q1
$101K Buy
1,528
+1,205
+373% +$74.4K ﹤0.01% 2719
2023
Q4
$18.3K Buy
+323
New +$16.9K ﹤0.01% 3327
2023
Q3
Sell
-577
Closed -$38.8K 2642
2023
Q2
$38.8K Buy
+577
New +$35.2K ﹤0.01% 3166

Other funds holding LMAT

Pacer Advisors's LMAT Position: Q1 2026 in Review

Pacer Advisors increased its LeMaitre Vascular (LMAT) stake by 46% in Q1 2026, buying an estimated $64.9K and bringing the position to 2,172 shares worth $237K. The position accounts for ﹤0.01% of the portfolio, ranked #1709.

Pacer Advisors first reported a position in LMAT in Q2 2023 and has held it in 11 quarters since. The position peaked at $272K in Q4 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Pacer Advisors held 2,172 shares of LeMaitre Vascular worth $237K as of Q1 2026.
  • Pacer Advisors bought 681 LeMaitre Vascular shares in Q1 2026, an estimated $64.9K.
  • LeMaitre Vascular made up ﹤0.01% of Pacer Advisors's portfolio in Q1 2026, its #1709 holding.
  • Pacer Advisors first reported a position in LeMaitre Vascular in Q2 2023 and has held it in 11 quarters since.
  • Pacer Advisors's LeMaitre Vascular position peaked at $272K in Q4 2024.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.